🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Apply now for EMBO Workshop on Liver and pancreas in metabolic disease: from pathways to therapies 02 – 04 April 2025 in Sant Feliu de Guíxols (Girona), Spain 📜 Registration deadline: 14 February 2025 meetings.embo.org/event/25-liver… #EMBOliverPancreas

We have added an additional date for our free face to face Advanced Hybrid Closed Loop day on the 24th April 2025, Early booking is advised. Facilitated by Geraldine Gallen and Dr Sufyan Hussain.   Link is here – diabetes-nnf.co.uk/events/kings-h…

Getting your ducks in a row to deliver HCL in Scotland Diabetes UK Diabetes Technology Network UK DTN-UK Advanced Technologies & Treatments for Diabetes #DUKAPC2025

Next up at #DUKPC, let’s dive into detecting and treating ‘pre-symptomatic type 1 diabetes’. ⚒️ We have the tools to identify type 1 at its very early stages, before symptoms appear or treatment is needed.

Elizabeth Robertson Rachel Ann Connor Firstly we’re hearing from Dr Rocio Sancho, Prof Shanta Persaud, Prof Shareen Forbes and Prof David Hodson with their various approaches moving us closer to the bench by beta cell therapies for #T1D #DUKPC2025

On now to Prof Shareen Forbes from Edinburgh taking us through how cell therapies fit in to the picture of T1D management options, and discusses the experience of islet transplantation within the UK #DUKPC25

On now to discussing the work being funded by Breakthrough T1D looking at using alternatively activated macrophages to support islets in the transplant setting and the #Type1DiabetesGrandChallenge programme (which Prof Forbes also described in yesterdays Grand Challenge session)

Breakthrough T1D Under questions Prof Forbes describes how the approaches she described may help significantly reduce levels of immune suppression, but suspects some immune therapy (perhaps especially immune modulation to control autoimmunity?) may still be needed #dukpc2025

Thanks to Diabetes UK for the invitation to speak at this important symposium. Eliminating or reducing immunosuppression in sc islet transplantation is an important goal.

Wonderful that Diabetes UK invited Prof Peter Senior from Canada to share 20 year outcome data from the Edmonton islet transplant programme. One of three great speakers in an inspiring session ending this year’s Professional Conference

Thanks Jim it's good to see an active simultaneous islet kidney programme in the UK which can really benefit our type 1 diabetes recipients.

1/ 🧵How much does it cost to save the life of a person living with diabetes? We (@ScottLeibrand & I) did the math to re-assess how cost-effective Life for a Child is in supporting children with diabetes in low-income countries. Here’s what we found:

Our recent large-scale analysis of #BoneMarrowAdiposity in the UK Biobank has been voted as Paper of the Month by BMAS. I'm honoured and delighted that our work has been recognised by this growing research community! EdinUniCVS EdinUniMetabolism Usher Institute

This #InternationalWomensDay we’d like to invite you to celebrate all the women who are pioneering #diabetes #research 🥼 🔬 like Professor Claire Meek. Her research focuses on improving care for people & babies affected by diabetes in pregnancy, including gestational diabetes.

Well done and well deserved!

On #InternationalWomensDay2025 so grateful for these amazing scientists working to improve the lives of children and adults with diabetes Stanford Pediatrics StanfordPedsEndo

Congratulations Naveed on all the important work that you and team have done over the years. Excellent that this has been recognised.

Type 1 diabetes community! 📢 Don’t miss out on our family-friendly T1D community event taking place in Newcastle! Meet other people and families living with T1D, take part in activities, share experiences, and feel supported 💙 Sign up for free today 👉

💡New study published in @DiabeticMedicine reports that dangerous low blood sugars (hypos) are less common than before in people with #Type1Diabetes, and this is likely thanks to tech like CGMs and insulin pumps.